Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

ClinicalTrials.gov ID: NCT05978531

Public ClinicalTrials.gov record NCT05978531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 5:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Observational Study of Bafiertam Evaluating Persistence on Treatment, Safety, Tolerability, and Effectiveness in Routine Clinical Practice.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, multicenter, observational study of the adherence of patients with relapsing-remitting multiple sclerosis (RRMS) prescribed Bafiertam (monomethyl fumarate) as their treatment.

Study identification

NCT ID
NCT05978531
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Banner Life Sciences LLC
Industry
Enrollment
25 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 16, 2023
Primary completion
Feb 23, 2025
Completion
Feb 23, 2025
Last update posted
Mar 5, 2025

2023 – 2025

United States locations

U.S. sites
9
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Gilbert Neurology Gilbert Arizona 85297 —
Center for Neurology and Spine Phoenix Arizona 85032 —
Perseverance Research Center, LLC Scottsdale Arizona 85253 —
Clinical Endpoints Scottsdale Arizona 85258 —
Regina Berkovich MD PhD Inc. West Hollywood California 90048 —
Comprehensive Neurology Clinics of Bethesda Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817 —
Maryland Center for Neurology and Sleep Glen Burnie Maryland 21061 —
Holy Name Medical Center Teaneck New Jersey 07666 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05978531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2025 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05978531 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →